Plan builds upon President Biden’s September action directing more than $2bn to accelerate production of rapid tests and an additional $1bn investment in procuring at-home tests. • Source: Alamy
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
